Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Albuminuria Lowering Therapies to Individual Patients With CKD Using FINErenone and SEmaglutide

NCT07819227 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07819227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Albuminuria Lowering Therapies to Individual Patients With CKD Using FINErenone and SEmaglutide
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Completed
Start date
February 11, 2025
Completion date
August 31, 2026
Enrollment
41 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease